¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Interstitial pulmonary disease, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin S-C disease
    Çì¸ð±Û·ÎºóS-Cº´
  • hemolytic disease
    ¿ëÇ÷º´
  • hemorrhagic disease
    ÃâÇ÷º´
  • hepatolenticular disease
    °£·»ÁîÇÙº´
  • hereditary disease
    À¯Àüº´
  • heredodegenerative disease
    À¯Àüº¯¼ºº´
  • herpetic disease
    Ç츣Æä½ºº´
  • hidebound disease
    Çǰñ»óÁ¢º´
  • hip-joint disease
    ¾ûµ¢°üÀýº´, °í°üÀýº´
  • Hirschsprung¡¯s disease
    È÷¸£½´½´ÇÁ·îº´
  • hand-foot-mouth disease
    ¼Õ¹ßÀÔº´
  • Hand-Schuller-Christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÃµº´
  • Hodgkin¡¯s disease
    È£ÁöŲº´
  • holoendemic disease
    ¼Ò¾ÆÇ³Å亴
  • hookworm disease
    ±¸Ã溴
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • hyperbaric disease
    °í¾Ðº´
  • hyperendemic disease
    °ú´ÙºóµµÇ³Å亴
  • hypertensive disease
    °íÇ÷¾ÐÁúȯ
  • hypertensive heart disease
    °íÇ÷¾Ð½ÉÀ庴, °íÇ÷¾Ð½ÉÀåÁúȯ
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
  • iatrogenic disease
    ¿øÀÎºÒ¸íº´
  • idiopathic disease
    Ư¹ßº´, Àڹߺ´
  • immune deposit disease
    ¸é¿ªÄ§Âøº´
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • immunological disease
    ¸é¿ªÁúȯ
  • immunoproliferative disease
    ¸é¿ª¼¼Æ÷Áõ½Äº´
  • imported disease
    ¼öÀÔº´
  • inclusion disease
    Æ÷ÇÔº´, ºÀÀÔº´
  • industrial disease
    »ê¾÷º´, Á÷¾÷º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • pulmonary vasculature
    Æó¸Æ°ü°è, Æó¸Æ°ü ±¸Á¶.
  • pulmonary vasculature
    Æó¸Æ°ü°è, Æó¸Æ°ü
  • pulmonary vein
    ÆóÁ¤¸Æ(øËð¡Øæ).
  • pulmonary vein
    ÇãÆÄÁ¤¸Æ
  • pulmonary vein
    ÆóÁ¤¸Æ(øËð¡Øæ).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â (¡­øÍáð).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â(øËð¡ØæøÍáð)
  • pulmonary ventilatory capacity
    Æóȯ±â¿ë·®.
  • pulmonary viscosity
    ÆóÁ¡¼º(øËïÄàõ).
  • pulmonary wedge pressure
    Æó½û±â¾Ð.
  • ABO hemolytic disease
    ABO ¿ëÇ÷¼º Áúȯ(¡­éÁúìàõ òðü´)
  • ABO hemolytic disease of the newborn
    ½Å»ý¾Æ ABO ¿ëÇ÷¼ºÁúȯ
  • Addisons disease
    ¾Æµð¼Õ º´
  • Addisons disease
    ¾Öµð½¼º´ ºÎ½Å±â´ÉºÎÀü .
  • Aleutian mink disease virus
    ¾Ë·ù»ê¹ÖÅ©º´ ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hyaline membranes
    ÆóÀ¯¸® Áú¸·(øË¡­òõد)
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, Æó°íÇ÷¾ÐÁõ.
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð(øËÔÑØæÍÔúìäâ), Æó°íÇ÷¾ÐÁõ(øËÍÔúìäâñø)
  • pulmonary hypertrophic osteopathy
    Æó¼º ºñ´ë¼º °ñº´Áõ.
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º °ñº´Áõ(øËàõÝþÓÞàõ ÍéÜ»ñø)
  • pulmonary incompetence
    Æóµ¿¸ÆÆÇºÎÀü(Áõ)(øËÔÑØæ÷ûÝÕîïñø).
  • pulmonary incompetence
    Æóµ¿¸ÆÆÇºÎÀü(Áõ)(øËÔÑØæ÷ûÝÕîï(ñø))
  • pulmonary infarct
    Æó°æ»ö.
  • pulmonary infarct
    Æó°æ»ö(øËÌÛßá)
  • pulmonary infarction
    Æó°æ»ö
  • pulmonary infarction
    Æó°æ»öÁõ(øËÌÛßáñø)
  • pulmonary infection
    Æó°¨¿°(øËÊïæø).
  • pulmonary infection
    Æó°¨¿°(øËÊïæø)
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ).
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
PT pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t...
PV pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc...
PVC peripheral venous catheterization; persistent vaginal cornification; polyvinyl chloride; postvoiding...
COPD Chronic Obstructive Pulmonary Disease; ¸¸¼º Æó¼â¼º ÆóÁúȯ
TB, Tb TuBerculosis; °áÇÙ
  = Tbc
  ? CIX of Op
    1. Pulm...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
PPHN Persistent Pulmonary Hypertension of the Newborn
PPH Persistent pulmonary hypertension
PPHN Persistent pulmonary hypertension
PPC Postoperative pulmonary complications
PPH Primary Pulmonary Hypertension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Marek's disease
    ¸¶·¹Å© º´
    Æ÷Áø ¹ÙÀÌ·¯½º
  • margarine disease
    ¸¶°¡¸° º´
    ´ÙÇü¼º È«¹ÝÀ¸·Î¼­ oleomargarineÁßÀÇ À¯È­Á¦°¡ ¿øÀÎÀÌ´Ù. µ¶ÀÏ, ¿À¶õ´Ù¿¡¼­ Æø¹ßÀûÀ¸·Î À¯ÇàÇÏ¿´À¸¸ç ´ç½Ã´Â Àü¿°¼ºÀ̶ó°í »ý°¢Çß´Ù.
  • medullary cystic disease
    ¼öÁú³¶¼º Áúȯ
  • mental disease
    Á¤½Åº´
    ±â´ÉÀû ¿øÀΰú ±âÁúÀûÀÎ ¿øÀÎÀ» Æ÷ÇÔÇÑ ¸ðµç Á¤½Åº´.
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metabolic disease
    ´ë»ç¼º Áúȯ
    ½Åü ¼¼Æ÷ÀÇ È­ÇйÝÀÀÀÇ Àå¾Ö°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ.
  • Mikulicz's disease
    ¹ÌŬ¸¯Âê¾¾º´, ¹ÌÄð¸®Ã÷º´
    ¹ÌÁöÀÇ ¿øÀο¡ ÀÇÇÑ ´©¼± ¹× Ÿ¾×¼±ÀÇ ¾ç¼º ÀÚ±â ÇÑÁ¤¼º ¸²ÇÁ±¸ ħÀ±°ú Á¾Ã¢À¸·Î¼­, Á߳⠶Ǵ ³ë³âÀÇ ºÎÀο¡°Ô ¹ßº´ÇÑ´Ù. Sjögren ÁõÈıº°ú µ¿ÀÏÇÏ´Ù°í »ý°¢ÇÏ´Â »ç¶÷µéµµ ÀÖ´Ù. ¶Ç´Â °øÅëÀÇ º´ÀÎÀ» °¡Áø µ¿ÀÏ ÁúȯÀÇ ÀÌÇüÀ̶ó°í ÇÏ´Â »ç¶÷µµ ÀÖ´Ù. À¯À°Á¾Áõ, ¾Ç¼º ¸²ÇÁÁ¾, ±³¿øº´ µî¿¡¼­ µ¿ÀÏÇÑ ÀÓ»ó ¼Ò°ßÀ» º¼ ¶§, Mikulicz ÁõÈıºÀ̶ó°í ÇÑ´Ù.
  • mitral valvular disease
    ½Â¸ðÆÇ¸· Áúȯ
  • molecular disease
    ºÐÀÚ º´
    Ç÷»ö¼Ò ºÐÀÚÀÇ ±Û·Îºó ÀÌ»ó¿¡ ÀÇÇÑ ÀÌ»ó Ç÷»ö¼ÒÀÇ Á¸Àç¿¡ ÀÇÇØ ¹ß»ýÇϴ Ư¼öÇÑ ºóÇ÷¿¡ ´ëÇÏ¿© PaulingÀÌ ºÙÀÎ ¸íĪ.
  • motor neuron disease
    ¿îµ¿ ´º·± Áúȯ
    ¿îµ¿ ½Å°æ¿ø¼º Áúȯ, ¿îµ¿ ½Å°æ ´º·±ÀÇ ÁúȯÀ¸·Î¼­ ô¼ö ½Å°æ À§Ãà, ÁøÇ༺ ±¸»ó ¸¶ºñ, ±ÙÀ§Ã༺ Ãà»è °æÈ­Áõ, Ãà»è °æÈ­Áõ µîÀ» ¸ðµÎ Æ÷ÇÔÇÑ´Ù.
  • motor neurone disease
    ¿îµ¿ ½Å°æ¿ø¼º Áúȯ
  • motor system disease
    ¿îµ¿°è Àå¾Ö
  • mountain disease
    °í»êº´, »ê¾Çº´, »ê¸Ö¹Ì
    Àú»ê¼ÒÁõÀ» ÀÏÀ¸Å°±â¿¡´Â ÃæºÐÇÑ °í¼Ò¿¡ ³ëÃâµÊÀ¸·Î½á ÀϾ´Â ÁõÈıºÀ¸·Î¼­, °¨¼ÒµÈ ´ë±â¾Ð°ú ÀÌ¿¡ µû¸£´Â µ¿¸ÆÇ÷ÀÇ »ê¼Ò ÇÔ·® ÀúÇÏÀÇ °á°ú·Î ÀϾ´Ù. ±Þ¼ºÇü
  • Moyamoya disease
    ¸ð¾ß¸ð¾ß º´
    1. ³»°æ µ¿¸Æ ¸»´ÜºÎ¿¡ ÇùÂø, Æó»öÀÇ ¾ç»óÀÌ ³ªÅ¸³ª´Â Áúȯ.Àª¸®½º µ¿¸Æ·û Æó»öÁõ, ³úÀúºÎ ÀÌ»ó Ç÷°ü¸ÁÁõÀ̶ó°íµµ ÇÑ´Ù. µ¹¹ß¼º ³ú Ç÷°ü ºÎÀüÁõ¿¡¼­ º¼ ¼ö Àִµ¥ ³ú ÀúºÎÀÇ Á¤»ó Ç÷°ü ´ë½Å¿¡ ¼Òµ¿¸ÆÀÇ Èñ¹ÌÇÑ ±×¹° ¸ð¾ç
  • mucosal disease
    Á¡¸· º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
alexander disease <radiology> Dysmyelinating disease, rare, sporadic, usually presents in 1st year, gradual enlargement of head (Differential diagnosis: Canavan disease), retardation, convulsion, spasticity CT findings: decreased density of white matter, frontal lobe predominance, with or without dilated lateral ventricles Diagnosis: brain biopsy
(12 Dec 1998)
Alexander's disease A rare, fatal central nervous system degenerative disease of infants, characterised by psychomotor retardation, seizures, and paralysis; megaloencephaly is associated with widespread leukodystrophic changes, especially in the frontal lobes.
(05 Mar 2000)
alkali disease A term applied to various animal poisonings of plant and mineral origin in arid regions under the belief that they were caused by the ingestion of alkaline waters; e.g., botulism of wild ducks, caused by feeding on decayed vegetation in nearly dried-up lakes.
(05 Mar 2000)
Almeida's disease <microbiology> A chronic fungal infection caused by Paracoccidioides brasiliensis.
It is characterised by primary pulmonary lesions with dissemination to many visceral organs.
Common findings include ulcerative granuloma lesions to the buccal mucosa (inner lining of the cheek) and nasal mucosa that extend to the surrounding skin. Generalised lymphangitis is also typical.
More commonly seen in South America and the tropics.
(15 Nov 1997)
Alpers disease Familial progressive spastic paresis of extremities with progressive mental deterioration, with development of seizures, blindness and deafness, beginning during the first year of life, and with destruction and disorganization of nerve cells of the cerebral cortex.
Synonym: Alpers disease, Christensen-Krabbe disease, progressive cerebral poliodystrophy.
(05 Mar 2000)
alpha chain disease A vague or indefinite term; could be used for alpha-heavy-chain disease (a lymphoplasma cell proliferative disease usually seen in Mediterranean men, characterised by intestinal involvement with steatorrhoea, often progressive with fatal outcome) or a thalassaemia (a genetic abnormality in the alpha globin chain of haemoglobin).
(05 Mar 2000)
altitude disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
alzheimer disease A degenerative organic mental disease characterised by progressive brain deterioration and dementia. The disease was originally described as dementia, presenile occurring in persons under the age of 65 (as opposed to dementia, senile with onset at or after 65); however, onset may occur at any age. There is no pathophysiological nor clinical distinction between the two stages of onset of alzheimer's. Women appear to be affected twice as frequently as men. It is characterised pathologically by the triad of senile plaques, neurofibrillary tangles, and neuropil threads.
(12 Dec 1998)
Alzheimer's disease <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes.
Alzheimer's disease is the most common cause of dementia.
(22 May 1997)
anaemia of chronic disease <disease> A form of anaemia which develops as the result of a long-term infection or illness. Chronic diseases can interfere with red blood cell production in addition to shortening red blood cell life span in the body.
Symptoms are largely due to the underlying disease. Haemoglobin and haematocrit are generally low. Iron studies may be low to normal. Red blood cell indices may usually normal.
(27 Sep 1997)
anarthritic rheumatoid disease Rheumatoid disease without arthritis.
(05 Mar 2000)
Anders' disease <disease> A disease accompanied by painful localised fatty swellings and by various nerve lesions. It is usually seen in women and may cause death from pulmonary complications.
(12 Dec 1998)
Andersen's disease Familial cirrhosis of the liver with storage of abnormal glycogen; glycogenosis due to deficiency of 1,4-alpha-glucan branching enzyme, resulting in accumulation of abnormal glycogen with long inner and outer chains in liver, kidney, muscle, and other tissues.
Synonym: Andersen's disease.
(05 Mar 2000)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á